Fulgent Genetics, Inc. (FLGT)
14.97
+0.20
(+1.35%)
USD |
NASDAQ |
Mar 16, 11:33
Fulgent Genetics Total Assets (Quarterly) : 1.214B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Delcath Systems, Inc. | 161.99M |
| Quest Diagnostics, Inc. | 16.22B |
| CytoSorbents Corp. | 45.75M |
| Cardiac Biotech Solutions, Inc. | 0.3773M |
| Odyssey Health, Inc. | 0.7213M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 106.81M |
| Shareholders Equity (Quarterly) | 1.112B |
| Debt to Equity Ratio | 0.0072 |
| Current Ratio | 6.479 |
| Net Debt Paydown Yield | 0.05% |